<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0001100663</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000076483</seriesId>
        <classId>C000236410</classId>
      </seriesClassInfo>


    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>iShares Trust</regName>
      <regFileNumber>811-09729</regFileNumber>
      <regCik>0001100663</regCik>
      <regLei>5493000860OXIC4B5K91</regLei>
      <regStreet1>400 Howard Street</regStreet1>
      <regCity>San Francisco</regCity>
      <regStateConditional regCountry="US" regState="US-CA"/>
      <regZipOrPostalCode>94105</regZipOrPostalCode>
      <regPhone>800-474-2737</regPhone>
      <seriesName>iShares Neuroscience and Healthcare ETF</seriesName>
      <seriesId>S000076483</seriesId>
      <seriesLei>549300JGI839T0141L50</seriesLei>
      <repPdEnd>2025-07-31</repPdEnd>
      <repPdDate>2025-04-30</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>4102232.12</totAssets>
      <totLiabs>701881.97</totLiabs>
      <netAssets>3400350.15</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>7708.47000000</cshNotRptdInCorD>
      <borrowers>
        <borrower aggrVal="39303.56982400" lei="BFM8T61CT2L1QCEMIK50" name="UBS AG"/>
        <borrower aggrVal="65217.38088600" lei="FOR8UP27PHTHYVLBNG30" name="GOLDMAN SACHS &amp; CO."/>
        <borrower aggrVal="90216.07069600" lei="ZBUT11V806EZRVTWT807" name="JP MORGAN SECURITIES LLC"/>
        <borrower aggrVal="151872.00000000" lei="VYVVCKR63DVZZN70PB21" name="Wells Fargo Securities LLC"/>
      </borrowers>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000236410" rtn1="-4.08000000" rtn2="-10.24000000" rtn3="1.41000000"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
          </equityContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="-30402.47000000" netUnrealizedAppr="-128558.99000000"/>
        <othMon2 netRealizedGain="-59286.70000000" netUnrealizedAppr="-324967.58000000"/>
        <othMon3 netRealizedGain="23258.82000000" netUnrealizedAppr="24648.43000000"/>
      </returnInfo>
      <mon1Flow redemption="0.00000000" reinvestment="0.00000000" sales="0.00000000"/>
      <mon2Flow redemption="0.00000000" reinvestment="0.00000000" sales="0.00000000"/>
      <mon3Flow redemption="0.00000000" reinvestment="0.00000000" sales="0.00000000"/>



    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>H Lundbeck A/S</name>
        <lei>5493006R4KC2OI5D3470</lei>
        <title>H Lundbeck A/S</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="DK0061804770"/>
        </identifiers>
        <balance>20922.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="DKK" exchangeRt="6.58900000"/>
        <valUSD>100122.48000000</valUSD>
        <pctVal>2.944475585845</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Taysha Gene Therapies Inc</name>
        <lei>N/A</lei>
        <title>Taysha Gene Therapies Inc</title>
        <cusip>877619106</cusip>
        <identifiers>
          <isin value="US8776191061"/>
        </identifiers>
        <balance>12431.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>24116.14000000</valUSD>
        <pctVal>0.709225195528</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Anavex Life Sciences Corp</name>
        <lei>549300K1I5L8COCQ8W36</lei>
        <title>Anavex Life Sciences Corp</title>
        <cusip>032797300</cusip>
        <identifiers>
          <isin value="US0327973006"/>
        </identifiers>
        <balance>6441.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>61189.50000000</valUSD>
        <pctVal>1.799505853830</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="60572.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Entrada Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Entrada Therapeutics Inc</title>
        <cusip>29384C108</cusip>
        <identifiers>
          <isin value="US29384C1080"/>
        </identifiers>
        <balance>1742.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15904.46000000</valUSD>
        <pctVal>0.467730065975</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Solid Biosciences Inc</name>
        <lei>N/A</lei>
        <title>Solid Biosciences Inc</title>
        <cusip>83422E204</cusip>
        <identifiers>
          <isin value="US83422E2046"/>
        </identifiers>
        <balance>4692.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15530.52000000</valUSD>
        <pctVal>0.456732963221</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Catalyst Pharmaceuticals Inc</name>
        <lei>5299004O0R5XXLA5H544</lei>
        <title>Catalyst Pharmaceuticals Inc</title>
        <cusip>14888U101</cusip>
        <identifiers>
          <isin value="US14888U1016"/>
        </identifiers>
        <balance>6999.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>170005.71000000</valUSD>
        <pctVal>4.999653050436</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dyne Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Dyne Therapeutics Inc</title>
        <cusip>26818M108</cusip>
        <identifiers>
          <isin value="US26818M1080"/>
        </identifiers>
        <balance>6561.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>77354.19000000</valUSD>
        <pctVal>2.274888955185</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Axogen Inc</name>
        <lei>N/A</lei>
        <title>Axogen Inc</title>
        <cusip>05463X106</cusip>
        <identifiers>
          <isin value="US05463X1063"/>
        </identifiers>
        <balance>3268.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>53170.36000000</valUSD>
        <pctVal>1.563673082314</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dynavox Group AB</name>
        <lei>5493008X1XZR4R5R0P66</lei>
        <title>Dynavox Group AB</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="SE0017105620"/>
        </identifiers>
        <balance>7515.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="SEK" exchangeRt="9.66550000"/>
        <valUSD>67682.04000000</valUSD>
        <pctVal>1.990443248910</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MicroPort NeuroScientific Corp</name>
        <lei>N/A</lei>
        <title>MicroPort NeuroScientific Corp</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="KYG6083E1098"/>
        </identifiers>
        <balance>16000.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="HKD" exchangeRt="7.75560000"/>
        <valUSD>21617.04000000</valUSD>
        <pctVal>0.635729823294</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Contineum Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Contineum Therapeutics Inc</title>
        <cusip>21217B100</cusip>
        <identifiers>
          <isin value="US21217B1008"/>
        </identifiers>
        <balance>999.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4105.89000000</valUSD>
        <pctVal>0.120749035213</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SK Biopharmaceuticals Co Ltd</name>
        <lei>N/A</lei>
        <title>SK Biopharmaceuticals Co Ltd</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="KR7326030004"/>
        </identifiers>
        <balance>2080.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="KRW" exchangeRt="1421.50000000"/>
        <valUSD>155973.77000000</valUSD>
        <pctVal>4.586991430867</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vanda Pharmaceuticals Inc</name>
        <lei>529900AY8VOOQBKJ0O70</lei>
        <title>Vanda Pharmaceuticals Inc</title>
        <cusip>921659108</cusip>
        <identifiers>
          <isin value="US9216591084"/>
        </identifiers>
        <balance>4256.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19194.56000000</valUSD>
        <pctVal>0.564487748416</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Supernus Pharmaceuticals Inc</name>
        <lei>549300GRM36VBKISYJ58</lei>
        <title>Supernus Pharmaceuticals Inc</title>
        <cusip>868459108</cusip>
        <identifiers>
          <isin value="US8684591089"/>
        </identifiers>
        <balance>4168.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>135376.64000000</valUSD>
        <pctVal>3.981255871546</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alector Inc</name>
        <lei>549300Z8RQOIY1JMHC25</lei>
        <title>Alector Inc</title>
        <cusip>014442107</cusip>
        <identifiers>
          <isin value="US0144421072"/>
        </identifiers>
        <balance>5526.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6631.20000000</valUSD>
        <pctVal>0.195015210418</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioArctic AB</name>
        <lei>549300Y0OI2WVUNHLC33</lei>
        <title>BioArctic AB</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="SE0010323311"/>
        </identifiers>
        <balance>3058.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="SEK" exchangeRt="9.66550000"/>
        <valUSD>62179.74000000</valUSD>
        <pctVal>1.828627560605</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="61549.40158200"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Biogen Inc</name>
        <lei>W8J5WZB5IY3K0NDQT671</lei>
        <title>Biogen Inc</title>
        <cusip>09062X103</cusip>
        <identifiers>
          <isin value="US09062X1037"/>
        </identifiers>
        <balance>1020.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>123501.60000000</valUSD>
        <pctVal>3.632025954738</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ceribell Inc</name>
        <lei>N/A</lei>
        <title>Ceribell Inc</title>
        <cusip>15678C102</cusip>
        <identifiers>
          <isin value="US15678C1027"/>
        </identifiers>
        <balance>1576.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>25357.84000000</valUSD>
        <pctVal>0.745742023067</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BlackRock Funds III</name>
        <lei>5493008LW2651I1QB503</lei>
        <title>BlackRock Cash Funds: Institutional, SL Agency Shares</title>
        <cusip>066922519</cusip>
        <identifiers>
          <isin value="US0669225197"/>
        </identifiers>
        <balance>349813.23000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>349953.15000000</valUSD>
        <pctVal>10.29167981420</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="349953.15000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ACADIA Pharmaceuticals Inc</name>
        <lei>529900O3044NO0PEA039</lei>
        <title>ACADIA Pharmaceuticals Inc</title>
        <cusip>004225108</cusip>
        <identifiers>
          <isin value="US0042251084"/>
        </identifiers>
        <balance>8751.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>127764.60000000</valUSD>
        <pctVal>3.757395396471</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Biohaven Ltd</name>
        <lei>N/A</lei>
        <title>Biohaven Ltd</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="VGG1110E1079"/>
        </identifiers>
        <balance>5146.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>113829.52000000</valUSD>
        <pctVal>3.347582307075</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>VG</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Santhera Pharmaceuticals Holding AG</name>
        <lei>54930035HAOFTTQH0U85</lei>
        <title>Santhera Pharmaceuticals Holding AG</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="CH1276028821"/>
        </identifiers>
        <balance>870.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="CHF" exchangeRt="0.82535000"/>
        <valUSD>15327.99000000</valUSD>
        <pctVal>0.450776811911</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dianthus Therapeutics Inc</name>
        <lei>549300Z3N6ODPCOFC890</lei>
        <title>Dianthus Therapeutics Inc</title>
        <cusip>252828108</cusip>
        <identifiers>
          <isin value="US2528281080"/>
        </identifiers>
        <balance>1539.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33627.15000000</valUSD>
        <pctVal>0.988931978078</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="31573.25000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cassava Sciences Inc</name>
        <lei>529900XA0UG5JXABYF08</lei>
        <title>Cassava Sciences Inc</title>
        <cusip>14817C107</cusip>
        <identifiers>
          <isin value="US14817C1071"/>
        </identifiers>
        <balance>3107.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4846.92000000</valUSD>
        <pctVal>0.142541790879</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Integra LifeSciences Holdings Corp</name>
        <lei>WB7IJCYY8YFTENS4O147</lei>
        <title>Integra LifeSciences Holdings Corp</title>
        <cusip>457985208</cusip>
        <identifiers>
          <isin value="US4579852082"/>
        </identifiers>
        <balance>5168.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>84703.52000000</valUSD>
        <pctVal>2.491023461216</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Climb Bio Inc</name>
        <lei>N/A</lei>
        <title>Climb Bio Inc</title>
        <cusip>28658R106</cusip>
        <identifiers>
          <isin value="US28658R1068"/>
        </identifiers>
        <balance>4653.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6235.02000000</valUSD>
        <pctVal>0.183364057375</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Denali Therapeutics Inc</name>
        <lei>549300ZTQ2HO18L3Q830</lei>
        <title>Denali Therapeutics Inc</title>
        <cusip>24823R105</cusip>
        <identifiers>
          <isin value="US24823R1059"/>
        </identifiers>
        <balance>9207.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>153296.55000000</valUSD>
        <pctVal>4.508257774570</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alto Neuroscience Inc</name>
        <lei>N/A</lei>
        <title>Alto Neuroscience Inc</title>
        <cusip>02157Q109</cusip>
        <identifiers>
          <isin value="US02157Q1094"/>
        </identifiers>
        <balance>1970.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4905.30000000</valUSD>
        <pctVal>0.144258672889</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zevra Therapeutics Inc</name>
        <lei>254900CU6T74V18Y1W18</lei>
        <title>Zevra Therapeutics Inc</title>
        <cusip>488445206</cusip>
        <identifiers>
          <isin value="US4884452065"/>
        </identifiers>
        <balance>4121.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30206.93000000</valUSD>
        <pctVal>0.888347630905</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avadel Pharmaceuticals PLC</name>
        <lei>549300E27PTSG2RHC762</lei>
        <title>Avadel Pharmaceuticals PLC</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="IE00BDGMC594"/>
        </identifiers>
        <balance>6896.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>61305.44000000</valUSD>
        <pctVal>1.802915502687</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bright Minds Biosciences Inc</name>
        <lei>N/A</lei>
        <title>Bright Minds Biosciences Inc</title>
        <cusip>10919W405</cusip>
        <identifiers>
          <isin value="CA10919W4056"/>
        </identifiers>
        <balance>550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16885.00000000</valUSD>
        <pctVal>0.496566508010</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Medincell SA</name>
        <lei>969500R79U6PXCL2FF46</lei>
        <title>Medincell SA</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="FR0004065605"/>
        </identifiers>
        <balance>1706.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="EUR" exchangeRt="0.88272900"/>
        <valUSD>29454.34000000</valUSD>
        <pctVal>0.866214910249</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="29143.56982400"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amylyx Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Amylyx Pharmaceuticals Inc</title>
        <cusip>03237H101</cusip>
        <identifiers>
          <isin value="US03237H1014"/>
        </identifiers>
        <balance>5063.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>25871.93000000</valUSD>
        <pctVal>0.760860760177</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Larimar Therapeutics Inc</name>
        <lei>529900NCBZHTTJV6HX73</lei>
        <title>Larimar Therapeutics Inc</title>
        <cusip>517125100</cusip>
        <identifiers>
          <isin value="US5171251003"/>
        </identifiers>
        <balance>2699.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7152.35000000</valUSD>
        <pctVal>0.210341573205</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Prothena Corp PLC</name>
        <lei>5299009ZXQ8NIIJ8OL30</lei>
        <title>Prothena Corp PLC</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="IE00B91XRN20"/>
        </identifiers>
        <balance>3313.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30479.60000000</valUSD>
        <pctVal>0.896366510960</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1738.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurogene Inc</name>
        <lei>529900A7VIY892SZVW73</lei>
        <title>Neurogene Inc</title>
        <cusip>64135M105</cusip>
        <identifiers>
          <isin value="US64135M1053"/>
        </identifiers>
        <balance>1371.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20565.00000000</valUSD>
        <pctVal>0.604790656632</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="13650.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xenon Pharmaceuticals Inc</name>
        <lei>549300XV44Q9Z1MIPQ03</lei>
        <title>Xenon Pharmaceuticals Inc</title>
        <cusip>98420N105</cusip>
        <identifiers>
          <isin value="CA98420N1050"/>
        </identifiers>
        <balance>4209.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>160783.80000000</valUSD>
        <pctVal>4.728448333475</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rapport Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Rapport Therapeutics Inc</title>
        <cusip>75383L102</cusip>
        <identifiers>
          <isin value="US75383L1026"/>
        </identifiers>
        <balance>1398.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16007.10000000</valUSD>
        <pctVal>0.470748578642</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Edgewise Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Edgewise Therapeutics Inc</title>
        <cusip>28036F105</cusip>
        <identifiers>
          <isin value="US28036F1057"/>
        </identifiers>
        <balance>5252.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>86132.80000000</valUSD>
        <pctVal>2.533056779461</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sarepta Therapeutics Inc</name>
        <lei>549300IKDPIED8J8IG21</lei>
        <title>Sarepta Therapeutics Inc</title>
        <cusip>803607100</cusip>
        <identifiers>
          <isin value="US8036071004"/>
        </identifiers>
        <balance>1492.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>93100.80000000</valUSD>
        <pctVal>2.737976852178</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Argenx SE</name>
        <lei>7245009C5FZE6G9ODQ71</lei>
        <title>Argenx SE</title>
        <cusip>04016X101</cusip>
        <identifiers>
          <isin value="US04016X1019"/>
        </identifiers>
        <balance>259.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>167091.26000000</valUSD>
        <pctVal>4.913942759689</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Idorsia Ltd</name>
        <lei>506700XOVZUB107S5720</lei>
        <title>Idorsia Ltd</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="CH0363463438"/>
        </identifiers>
        <balance>12319.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="CHF" exchangeRt="0.82535000"/>
        <valUSD>19339.02000000</valUSD>
        <pctVal>0.568736134424</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sangamo Therapeutics Inc</name>
        <lei>2549006WMRKRC4G32Z67</lei>
        <title>Sangamo Therapeutics Inc</title>
        <cusip>800677106</cusip>
        <identifiers>
          <isin value="US8006771062"/>
        </identifiers>
        <balance>14750.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11388.48000000</valUSD>
        <pctVal>0.334920802200</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neuren Pharmaceuticals Ltd</name>
        <lei>984500E48D0FDEE7CE63</lei>
        <title>Neuren Pharmaceuticals Ltd</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="NZNEUE0001S8"/>
        </identifiers>
        <balance>8775.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="AUD" exchangeRt="1.56115800"/>
        <valUSD>65432.81000000</valUSD>
        <pctVal>1.924296237550</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NZ</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Praxis Precision Medicines Inc</name>
        <lei>N/A</lei>
        <title>Praxis Precision Medicines Inc</title>
        <cusip>74006W207</cusip>
        <identifiers>
          <isin value="US74006W2070"/>
        </identifiers>
        <balance>1463.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>55067.32000000</valUSD>
        <pctVal>1.619460278230</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Voyager Therapeutics Inc</name>
        <lei>54930082S4XVR0ZWCC74</lei>
        <title>Voyager Therapeutics Inc</title>
        <cusip>92915B106</cusip>
        <identifiers>
          <isin value="US92915B1061"/>
        </identifiers>
        <balance>3598.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12808.88000000</valUSD>
        <pctVal>0.376692970869</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Design Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Design Therapeutics Inc</title>
        <cusip>25056L103</cusip>
        <identifiers>
          <isin value="US25056L1035"/>
        </identifiers>
        <balance>2279.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11075.94000000</valUSD>
        <pctVal>0.325729395838</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurocrine Biosciences Inc</name>
        <lei>549300FECER0XBN49756</lei>
        <title>Neurocrine Biosciences Inc</title>
        <cusip>64125C109</cusip>
        <identifiers>
          <isin value="US64125C1099"/>
        </identifiers>
        <balance>1360.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>146458.40000000</valUSD>
        <pctVal>4.307156426228</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SanBio Co Ltd</name>
        <lei>N/A</lei>
        <title>SanBio Co Ltd</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="JP3336750009"/>
        </identifiers>
        <balance>4100.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="JPY" exchangeRt="142.98000000"/>
        <valUSD>57731.82000000</valUSD>
        <pctVal>1.697819855405</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>JP</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Abeona Therapeutics Inc</name>
        <lei>54930002Z8PIJRCB4576</lei>
        <title>Abeona Therapeutics Inc</title>
        <cusip>00289Y206</cusip>
        <identifiers>
          <isin value="US00289Y2063"/>
        </identifiers>
        <balance>3063.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20093.28000000</valUSD>
        <pctVal>0.590917967668</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REGENXBIO Inc</name>
        <lei>549300EOES47LATSET33</lei>
        <title>REGENXBIO Inc</title>
        <cusip>75901B107</cusip>
        <identifiers>
          <isin value="US75901B1070"/>
        </identifiers>
        <balance>3484.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33481.24000000</valUSD>
        <pctVal>0.984640949403</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NeuroPace Inc</name>
        <lei>N/A</lei>
        <title>NeuroPace Inc</title>
        <cusip>641288105</cusip>
        <identifiers>
          <isin value="US6412881053"/>
        </identifiers>
        <balance>1770.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20691.30000000</valUSD>
        <pctVal>0.608504979994</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alkermes PLC</name>
        <lei>N/A</lei>
        <title>Alkermes PLC</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="IE00B56GVS15"/>
        </identifiers>
        <balance>4476.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>128774.52000000</valUSD>
        <pctVal>3.787095867171</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Scholar Rock Holding Corp</name>
        <lei>549300Z1FLPGL4OWJ459</lei>
        <title>Scholar Rock Holding Corp</title>
        <cusip>80706P103</cusip>
        <identifiers>
          <isin value="US80706P1030"/>
        </identifiers>
        <balance>4270.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>140525.70000000</valUSD>
        <pctVal>4.132683217932</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="138222.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PTC Therapeutics Inc</name>
        <lei>549300UJLWOIWFDGB318</lei>
        <title>PTC Therapeutics Inc</title>
        <cusip>69366J200</cusip>
        <identifiers>
          <isin value="US69366J2006"/>
        </identifiers>
        <balance>2923.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>145682.32000000</valUSD>
        <pctVal>4.284332894363</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Capricor Therapeutics Inc</name>
        <lei>5493002ZI5PDLXV4DX14</lei>
        <title>Capricor Therapeutics Inc</title>
        <cusip>14070B309</cusip>
        <identifiers>
          <isin value="US14070B3096"/>
        </identifiers>
        <balance>3119.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>39611.30000000</valUSD>
        <pctVal>1.164918265843</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="10160.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Annexon Inc</name>
        <lei>N/A</lei>
        <title>Annexon Inc</title>
        <cusip>03589W102</cusip>
        <identifiers>
          <isin value="US03589W1027"/>
        </identifiers>
        <balance>7586.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14109.96000000</valUSD>
        <pctVal>0.414956089154</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ClearPoint Neuro Inc</name>
        <lei>N/A</lei>
        <title>ClearPoint Neuro Inc</title>
        <cusip>18507C103</cusip>
        <identifiers>
          <isin value="US18507C1036"/>
        </identifiers>
        <balance>1869.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26894.91000000</valUSD>
        <pctVal>0.790945308970</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fulcrum Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Fulcrum Therapeutics Inc</title>
        <cusip>359616109</cusip>
        <identifiers>
          <isin value="US3596161097"/>
        </identifiers>
        <balance>3907.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15041.95000000</valUSD>
        <pctVal>0.442364737055</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <explntrNotes>
      <explntrNote note="Monthly returns presented in Item B.5(a) have been calculated without deducting any applicable sales loads or redemption fees." noteItem="B.5.a"/>





    </explntrNotes>
    <signature>
      <ncom:dateSigned>2025-05-30</ncom:dateSigned>
      <ncom:nameOfApplicant>iShares Trust</ncom:nameOfApplicant>
      <ncom:signature>Chuck Pulsfort</ncom:signature>
      <ncom:signerName>Chuck Pulsfort</ncom:signerName>
      <ncom:title>Assistant Treasurer</ncom:title>
    </signature>
  </formData>
  <documents>XXXX</documents>
</edgarSubmission>
